Proof Of Concept Fund

A pioneering anti-cancer drug, potentially 500 times more potent than current treatments, is one of 18 projects to receive a share of a new £2.95 million fund designed to commercialise ground-breaking academic research. The £2.95m Proof of Concept Fund will support the commercialisation